{"url_path":"/sec/ipsc/8-k/2026-06-12/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1850119/0001104659-26-073429-index.html","accession_number":"0001104659-26-073429","cik":"0001850119","ticker":"IPSC","issuer_name":"Century Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1850119/0001104659-26-073429-index.html","primary_entity_key":"0001850119","primary_entity_name":"Century Therapeutics, Inc."},"word_count":100,"has_tables":true,"body_markdown":"**Item 9.01****Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\n**Exhibit\nNo.**\n \n**Document**\n\n \n \n \n\n[3.1](tm2617728d1_ex3-1.htm)\n \n[Certificate of Amendment of the Second Amended and Restated Certificate of Incorporation, as amended, of Century Therapeutics, Inc.](tm2617728d1_ex3-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**CENTURY THERAPEUTICS, INC.**\n\n \n \n \n\n \nBy:\n/s/ Brent Pfeiffenberger, Pharm.D.\n\n \nName:\nBrent Pfeiffenberger, Pharm.D.\n\n \nTitle:\nPresident, Chief Executive Officer and Chairman of the Board of Directors\n\n \n\nDate: June 12, 2026"}